ALUMINIUM CHELATION THERAPY IN DIALYSIS PATIENTS: EVIDENCE FOR INHIBITION OF HAEMOGLOBIN SYNTHESIS BY LOW LEVELS OF ALUMINIUM
- 1 May 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8593), 1012-1015
- https://doi.org/10.1016/s0140-6736(88)91840-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Residual renal function in hemodialysis patients may protect against hyperaluminemiaKidney International, 1987
- Serum Aluminum Levels and Erythrocyte Dihydropteridine Reductase Activity in Patients on HemodialysisNew England Journal of Medicine, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Microcytic anemia secondary to intraperitoneal aluminum in normal and uremic ratsKidney International, 1984
- Plasma aluminum is bound to transferrinLife Sciences, 1983
- Reversal of Aluminum-Induced Hemodialysis Anemia by a Low-Aluminum DialysateNew England Journal of Medicine, 1982
- Are ‘Middle Molecules’ Responsible for Toxic Phenomena in Chronic Renal Failure?Nephron, 1982
- Changes in serum aluminium, blood zinc, blood lead and erythrocyte δ-aminolaevulinic acid dehydratase activity during haemodialysisToxicology Letters, 1979
- ALUMINIUM-INDUCED PORPHYRIA IN RATSThe Lancet, 1973